• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022

    2/18/22 10:06:59 AM ET
    $ADTH
    $API
    $ATUS
    $BEKE
    Computer Software: Programming Data Processing
    Technology
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADTH alert in real time by email

     

    Upgrades

    • Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $91.30 and a 52-week-low of $37.00. At the end of the last trading period, Denbury closed at $66.56.
    • For Pilgrims Pride Corp (NASDAQ:PPC), Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. In the fourth quarter, Pilgrims Pride showed an EPS of $0.56, compared to $0.25 from the year-ago quarter. The current stock performance of Pilgrims Pride shows a 52-week-high of $29.70 and a 52-week-low of $20.32. Moreover, at the end of the last trading period, the closing price was at $27.83.
    • According to Scotiabank, the prior rating for Marathon Oil Corp (NYSE:MRO) was changed from Sector Perform to Sector Outperform. For the fourth quarter, Marathon Oil had an EPS of $0.77, compared to year-ago quarter EPS of $0.12. At the moment, the stock has a 52-week-high of $22.56 and a 52-week-low of $9.11. Marathon Oil closed at $21.89 at the end of the last trading period.
    • According to Needham, the prior rating for Masimo Corp (NASDAQ:MASI) was changed from Hold to Buy. Masimo earned $1.21 in the fourth quarter, compared to $0.98 in the year-ago quarter. The current stock performance of Masimo shows a 52-week-high of $305.21 and a 52-week-low of $133.94. Moreover, at the end of the last trading period, the closing price was at $152.37.
    • According to JP Morgan, the prior rating for JB Hunt Transport Services Inc (NASDAQ:JBHT) was changed from Underweight to Neutral. In the fourth quarter, JB Hunt Transport Servs showed an EPS of $2.28, compared to $1.44 from the year-ago quarter. The stock has a 52-week-high of $208.87 and a 52-week-low of $140.88. At the end of the last trading period, JB Hunt Transport Servs closed at $187.84.
    • Raymond James upgraded the previous rating for Fastly Inc (NYSE:FSLY) from Outperform to Strong Buy. For the fourth quarter, Fastly had an EPS of $0.10, compared to year-ago quarter EPS of $0.09. The current stock performance of Fastly shows a 52-week-high of $97.98 and a 52-week-low of $19.13. Moreover, at the end of the last trading period, the closing price was at $19.20.
    • Atlantic Equities upgraded the previous rating for Nutrien Ltd (NYSE:NTR) from Underweight to Neutral. In the fourth quarter, Nutrien showed an EPS of $2.47, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $78.76 and a 52-week-low of $52.28. Nutrien closed at $77.17 at the end of the last trading period.
    • For Werner Enterprises Inc (NASDAQ:WERN), JP Morgan upgraded the previous rating of Underweight to Neutral. Werner Enterprises earned $1.13 in the fourth quarter, compared to $0.89 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.76 and a 52-week-low of $41.44. Werner Enterprises closed at $42.70 at the end of the last trading period.
    • According to JP Morgan, the prior rating for Cognex Corp (NASDAQ:CGNX) was changed from Underweight to Neutral. Cognex earned $0.30 in the fourth quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $92.17 and a 52-week-low of $61.59. At the end of the last trading period, Cognex closed at $61.65.

    See all analyst ratings upgrades.

     

    Downgrades

    • MoffettNathanson downgraded the previous rating for Altice USA Inc (NYSE:ATUS) from Buy to Neutral. Altice USA earned $0.56 in the fourth quarter, compared to $0.60 in the year-ago quarter. The current stock performance of Altice USA shows a 52-week-high of $38.19 and a 52-week-low of $11.12. Moreover, at the end of the last trading period, the closing price was at $11.83.
    • Benchmark downgraded the previous rating for Cooper-Standard Holdings Inc (NYSE:CPS) from Buy to Hold. Cooper-Standard Holdings earned $2.94 in the fourth quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $47.85 and a 52-week-low of $14.40. At the end of the last trading period, Cooper-Standard Holdings closed at $15.30.
    • According to Wells Fargo, the prior rating for Brady Corp (NYSE:BRC) was changed from Overweight to Equal-Weight. For the second quarter, Brady had an EPS of $0.70, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $61.76 and a 52-week-low of $48.27. At the end of the last trading period, Brady closed at $48.89.
    • According to Pivotal Research, the prior rating for Roku Inc (NASDAQ:ROKU) was changed from Hold to Sell. For the fourth quarter, Roku had an EPS of $0.17, compared to year-ago quarter EPS of $0.49. The current stock performance of Roku shows a 52-week-high of $490.76 and a 52-week-low of $139.47. Moreover, at the end of the last trading period, the closing price was at $144.71.
    • According to Goldman Sachs, the prior rating for Bilibili Inc (NASDAQ:BILI) was changed from Buy to Neutral. For the third quarter, Bilibili had an EPS of $0.65, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $153.57 and a 52-week-low of $28.32. Bilibili closed at $36.54 at the end of the last trading period.
    • Goldman Sachs downgraded the previous rating for Tencent Music Entertainment Group (NYSE:TME) from Neutral to Sell. In the third quarter, Tencent Music Enter Gr showed an EPS of $0.09, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.25 and a 52-week-low of $5.36. Tencent Music Enter Gr closed at $5.99 at the end of the last trading period.
    • According to JP Morgan, the prior rating for Heartland Express Inc (NASDAQ:HTLD) was changed from Overweight to Neutral. Heartland Express earned $0.26 in the fourth quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.07 and a 52-week-low of $14.02. Heartland Express closed at $14.49 at the end of the last trading period.
    • RBC Capital downgraded the previous rating for Redfin Corp (NASDAQ:RDFN) from Outperform to Sector Perform. In the fourth quarter, Redfin showed an EPS of $0.27, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $98.44 and a 52-week-low of $25.25. At the end of the last trading period, Redfin closed at $28.64.

    See all analyst ratings downgrades.

     

    Initiations

    • UBS initiated coverage on Constellation Energy Corp (NASDAQ:CEG) with a Neutral rating. The price target for Constellation Energy is set to $50.00. The current stock performance of Constellation Energy shows a 52-week-high of $56.57 and a 52-week-low of $43.88. Moreover, at the end of the last trading period, the closing price was at $45.29.
    • William Blair initiated coverage on Intellia Therapeutics Inc (NASDAQ:NTLA) with an Outperform rating. Intellia Therapeutics earned $0.97 in the third quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $202.73 and a 52-week-low of $43.86. At the end of the last trading period, Intellia Therapeutics closed at $90.40.
    • With a Buy rating, Stifel initiated coverage on Fathom Digital Manufacturing Corp (NYSE:FATH). The price target seems to have been set at $11.00 for Fathom Digital. The current stock performance of Fathom Digital shows a 52-week-high of $11.50 and a 52-week-low of $5.04. Moreover, at the end of the last trading period, the closing price was at $9.12.
    • With a Buy rating, B of A Securities initiated coverage on AdTheorent Holding Co Inc (NASDAQ:ADTH). The price target seems to have been set at $10.00 for AdTheorent Holding. The current stock performance of AdTheorent Holding shows a 52-week-high of $11.90 and a 52-week-low of $4.11. Moreover, at the end of the last trading period, the closing price was at $6.42.
    • With an Overweight rating, Cantor Fitzgerald initiated coverage on Oramed Pharmaceuticals Inc (NASDAQ:ORMP). The price target seems to have been set at $20.00 for Oramed Pharmaceuticals. Oramed Pharmaceuticals earned $0.22 in the first quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $31.54 and a 52-week-low of $6.98. Oramed Pharmaceuticals closed at $10.63 at the end of the last trading period.
    • Cantor Fitzgerald initiated coverage on vTv Therapeutics Inc (NASDAQ:VTVT) with an Overweight rating. The price target for vTv Therapeutics is set to $5.00. In the third quarter, vTv Therapeutics showed an EPS of $0.02, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.79 and a 52-week-low of $0.67. vTv Therapeutics closed at $0.71 at the end of the last trading period.
    • Benchmark initiated coverage on Bridgetown 2 Holdings Ltd (NASDAQ:BTNB) with a Buy rating. The price target for Bridgetown 2 Holdings is set to $17.00. The stock has a 52-week-high of $13.70 and a 52-week-low of $9.79. At the end of the last trading period, Bridgetown 2 Holdings closed at $9.97.
    • RBC Capital initiated coverage on Caribou Biosciences Inc (NASDAQ:CRBU) with an Outperform rating. The price target for Caribou Biosciences is set to $22.00. At the moment, the stock has a 52-week-high of $32.65 and a 52-week-low of $9.34. Caribou Biosciences closed at $10.22 at the end of the last trading period.
    • With an Outperform rating, RBC Capital initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV). The price target seems to have been set at $42.00 for Verve Therapeutics. For the third quarter, Verve Therapeutics had an EPS of $0.47, compared to year-ago quarter EPS of $3.81. The stock has a 52-week-high of $78.00 and a 52-week-low of $24.75. At the end of the last trading period, Verve Therapeutics closed at $28.02.
    • RBC Capital initiated coverage on Graphite Bio Inc (NASDAQ:GRPH) with a Sector Perform rating. The price target for Graphite Bio is set to $11.00. At the moment, the stock has a 52-week-high of $34.00 and a 52-week-low of $7.59. Graphite Bio closed at $10.99 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ADTH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTH
    $API
    $ATUS
    $BEKE

    CompanyDatePrice TargetRatingAnalyst
    Roku Inc.
    $ROKU
    2/13/2026$118.00Neutral → Buy
    Rosenblatt
    Fastly Inc.
    $FSLY
    2/12/2026Mkt Perform → Outperform
    William Blair
    Werner Enterprises Inc.
    $WERN
    2/6/2026$34.00Neutral → Sell
    Citigroup
    Roku Inc.
    $ROKU
    2/6/2026$105.00Perform → Outperform
    Oppenheimer
    Werner Enterprises Inc.
    $WERN
    2/6/2026$31.00 → $39.00Hold
    TD Cowen
    KE Holdings Inc
    $BEKE
    2/3/2026$19.00Buy → Neutral
    Goldman
    Werner Enterprises Inc.
    $WERN
    1/30/2026$31.00Hold
    TD Cowen
    Werner Enterprises Inc.
    $WERN
    1/29/2026$34.00Underperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ADTH
    $API
    $ATUS
    $BEKE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Szyman Catherine M. exercised 11,141 shares at a strike of $132.96 and covered exercise/tax liability with 4,568 shares (SEC Form 4)

    4 - MASIMO CORP (0000937556) (Issuer)

    2/13/26 5:28:49 PM ET
    $MASI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Willett Robert exercised 177,052 shares at a strike of $38.41 and sold $10,337,199 worth of shares (177,052 units at $58.39) (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    2/13/26 4:39:47 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    VP and PAO Macdonald Laura Ann sold $850,553 worth of shares (14,881 units at $57.16) and exercised 12,500 shares at a strike of $38.39, decreasing direct ownership by 52% to 2,212 units (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    2/13/26 4:33:52 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $ADTH
    $API
    $ATUS
    $BEKE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sabra Health Care REIT, Inc. to Attend Citi's 2026 Global Property CEO Conference

    Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer; Michael Costa, the company's Chief Financial Officer; Darrin Smith, the company's Chief Investment Officer; and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Citi's 2026 Global Property CEO Conference on March 1-4, 2026, at The Diplomat Beach Resort in Hollywood, Florida. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the

    2/13/26 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    vTv Therapeutics to Participate in Upcoming Investor Conferences

    HIGH POINT, N.C., Feb. 13, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (NASDAQ:VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today announced that management will participate in the following upcoming investor conferences: Oppenheimer 36th Annual Healthcare Life Sciences ConferenceDate: Thursday, February 26, 2026Time: 11:20 AM ETFormat: Presentation OnlyLocation: VirtualWebcast Link TD Cowen 46th Annual Health Care ConferenceDate: Tuesday, March 3, 2026Time: 9:50 AM ETFormat: Presentation and 1x1 MeetingsLocati

    2/13/26 8:00:00 AM ET
    $VTVT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Agora, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 2, 2026

    SANTA CLARA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ:API), a pioneer and leader in conversational AI and real-time engagement technology, will release its financial results for the fourth quarter and fiscal year ended December 31, 2025 after the close of U.S. markets on March 2, 2026. Agora, Inc. will host a conference call to discuss the financial results at 5 p.m. Pacific Time / 8 p.m. Eastern Time on the same day. Details for the conference call are as follows: Event title: Agora, Inc. 4Q 2025 Financial Results The call will be available at https://edge.media-server.com/mmc/p/9jcg52bqInvestors who want to hear the call should log on at least 15 minutes prior to t

    2/13/26 7:00:00 AM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    $ADTH
    $API
    $ATUS
    $BEKE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roku upgraded by Rosenblatt with a new price target

    Rosenblatt upgraded Roku from Neutral to Buy and set a new price target of $118.00

    2/13/26 8:26:09 AM ET
    $ROKU
    Cable & Other Pay Television Services
    Telecommunications

    Fastly upgraded by William Blair

    William Blair upgraded Fastly from Mkt Perform to Outperform

    2/12/26 7:17:35 AM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    Werner Enterprises downgraded by Citigroup with a new price target

    Citigroup downgraded Werner Enterprises from Neutral to Sell and set a new price target of $34.00

    2/6/26 8:17:11 AM ET
    $WERN
    Trucking Freight/Courier Services
    Industrials

    $ADTH
    $API
    $ATUS
    $BEKE
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by IREN Limited

    SCHEDULE 13G/A - IREN Ltd (0001878848) (Subject)

    2/13/26 5:14:55 PM ET
    $IREN
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Constellation Energy Corporation

    SCHEDULE 13G/A - Constellation Energy Corp (0001868275) (Subject)

    2/13/26 4:30:00 PM ET
    $CEG
    Electric Utilities: Central
    Utilities

    SEC Form 10-K filed by Cooper-Standard Holdings Inc.

    10-K - Cooper-Standard Holdings Inc. (0001320461) (Filer)

    2/13/26 4:20:46 PM ET
    $CPS
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ADTH
    $API
    $ATUS
    $BEKE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cohen Fred E bought $1,402,500 worth of shares (150,000 units at $9.35), increasing direct ownership by 261% to 207,453 units (SEC Form 4)

    4 - Intellia Therapeutics, Inc. (0001652130) (Issuer)

    1/7/26 4:05:06 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Exec VP-Chief Commercial Offcr Callahan Craig T bought $24,956 worth of shares (838 units at $29.77), increasing direct ownership by 1% to 65,080 units (SEC Form 4)

    4 - WERNER ENTERPRISES INC (0000793074) (Issuer)

    12/1/25 4:10:58 PM ET
    $WERN
    Trucking Freight/Courier Services
    Industrials

    Exec VP and COO Downing Eric J bought $25,645 worth of shares (862 units at $29.76), increasing direct ownership by 2% to 52,987 units (SEC Form 4)

    4 - WERNER ENTERPRISES INC (0000793074) (Issuer)

    12/1/25 4:09:40 PM ET
    $WERN
    Trucking Freight/Courier Services
    Industrials

    $ADTH
    $API
    $ATUS
    $BEKE
    Leadership Updates

    Live Leadership Updates

    View All

    J.B. Hunt Joins the Triumph Network

    Triumph (NYSE:TFIN), a financial and technology company focused on modernizing and simplifying freight transactions, today announced that J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) has joined the Triumph Network. J.B. Hunt, one of the largest supply chain solutions providers in North America, will adopt Triumph's advanced automated payment solution to accelerate and streamline carrier payment cycles. "J.B. Hunt's reputation as an innovator in transportation and logistics, combined with their commitment to embracing technology, makes them a true leader in our industry," said Triumph founder and chief executive officer, Aaron P. Graft. "Their decision to join the Triumph Network und

    1/22/26 4:07:00 PM ET
    $JBHT
    $TFIN
    Trucking Freight/Courier Services
    Industrials
    Major Banks
    Finance

    Clairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer; Joe Kiani Named Chairman of the Board

    BOSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Clairity, a U.S.-based medical technology company advancing AI-powered breast cancer risk assessment, today announced that its founder, Connie Lehman, MD, PhD, has assumed the role of Chief Executive Officer as the company enters its next phase of clinical adoption and growth. The company also announced Joe Kiani as Chairman of the Board of Directors. These leadership appointments reflect a pivotal moment for Clairity following FDA De Novo authorization of its mammography-based AI risk prediction platform and increasing engagement with health systems and partners worldwide. Clairity's innovation aligns with national priorities to improve health o

    1/21/26 4:30:00 PM ET
    $MASI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Appia Announces Appointment of VP Corporate Development

    Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Appia Rare Earths & Uranium Corp. (CSE:API) (OTCQB:APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) (the "Company" or "Appia") is pleased to announce that Jason Bagg has been appointed Vice-President Corporate Development, effective January 15, 2026. Mr. Bagg brings over 25 years of financial and uranium sector experience, including his position as Chief Executive Officer of Urano Energy Corp, and Puranium Energy Ltd. Tom Drivas, CEO of Appia, commented:"On behalf of the Board of Directors, it is my pleasure to welcome Jason to the Appia team. His experience in the financial markets and the uranium sector comes at a pivotal time as the Compa

    1/15/26 7:30:00 AM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    $ADTH
    $API
    $ATUS
    $BEKE
    Financials

    Live finance-specific insights

    View All

    Agora, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 2, 2026

    SANTA CLARA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ:API), a pioneer and leader in conversational AI and real-time engagement technology, will release its financial results for the fourth quarter and fiscal year ended December 31, 2025 after the close of U.S. markets on March 2, 2026. Agora, Inc. will host a conference call to discuss the financial results at 5 p.m. Pacific Time / 8 p.m. Eastern Time on the same day. Details for the conference call are as follows: Event title: Agora, Inc. 4Q 2025 Financial Results The call will be available at https://edge.media-server.com/mmc/p/9jcg52bqInvestors who want to hear the call should log on at least 15 minutes prior to t

    2/13/26 7:00:00 AM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    Cooper Standard Reports Strong Fourth Quarter Cash Flow Despite Industry Disruption; Continued Margin Expansion and Positive Cash Flow Highlight Full Year 2025 Results

    NORTHVILLE, Mich., Feb. 12, 2026 /PRNewswire/ -- Cooper-Standard Holdings Inc. (NYSE:CPS) today reported results for the fourth quarter and full year 2025. Fourth Quarter 2025 Summary Sales totaled $672.4 million, an increase of 1.8% vs. the fourth quarter of 2024Operating income totaled $0.6 million, a decrease of $31.1 million vs. the fourth quarter of 2024Net income of $3.3 million, or $0.18 per diluted share, reflected a decrease of $36.9 million vs. the fourth quarter of 2024Adjusted EBITDA totaled $34.9 million, or 5.2% of salesNet cash provided by operating activities o

    2/12/26 4:30:00 PM ET
    $CPS
    Auto Parts:O.E.M.
    Consumer Discretionary

    Roku Releases Fourth Quarter and Full Year 2025 Financial Results

    Today, Roku, Inc. (NASDAQ:ROKU) released fourth quarter and full year 2025 results. Visit the Roku investor relations website to view the fourth quarter and full year 2025 letter to shareholders. The company will host a live webcast of its conference call to discuss the results today at 2:00 PM Pacific Time. Participants may access the live webcast in listen-only mode on the Roku investor relations website. An archived webcast of the conference call will also be available following the call. About Roku Roku pioneered streaming on TV. We connect users to the content they love, enable content publishers to build and monetize large audiences, and provide advertisers with unique capabilit

    2/12/26 4:05:00 PM ET
    $ROKU
    Cable & Other Pay Television Services
    Telecommunications

    $ADTH
    $API
    $ATUS
    $BEKE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Caribou Biosciences Inc.

    SC 13D/A - Caribou Biosciences, Inc. (0001619856) (Subject)

    12/6/24 4:06:56 PM ET
    $CRBU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Verve Therapeutics Inc.

    SC 13G - Verve Therapeutics, Inc. (0001840574) (Subject)

    11/18/24 5:23:52 PM ET
    $VERV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Caribou Biosciences Inc.

    SC 13G/A - Caribou Biosciences, Inc. (0001619856) (Subject)

    11/14/24 7:53:54 PM ET
    $CRBU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care